BHEL: The company reported a Q4FY21 consolidated net loss of ₹1,036.32 crore, compared to ₹1,532 crore a year ago, it remained loss making at the operating level.
The company’s board has approved a final dividend of ₹3.50 per equity share of face value of ₹10 each for the financial year 2020-21, CIL said in a regulatory filing.
Pharma stocks: Indian pharmaceutical companies’ sales will grow robustly in the financial year ending March 2022 as sales normalise in categories affected by the pandemic in the previous year, said Fitch Ratings.
PNB Housing: The Reserve Bank of India and market regulator Sebi will look into various regulatory issues related to the proposed ₹4,000 crore-investment by US-based private equity firm Carlyle and others in PNB Housing Finance, people familiar with the matter said.
SBI Cards and Payment Services: The company has raised ₹500 crore by issuing bonds.
Tata Motors: The company said that its board has approved a proposal to raise up to ₹500 crore through the issue of securities on a private placement basis.